US Equity
NBIX
— NEUROCRINE BIOSCIENCES, INC.Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for neurological and endocrine-related diseases, including movement disorders.
💰 Market cap: $17.74B📍 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130 US🏷️ Pharmaceuticals💵 Previous close: $175.77🔢 4,084 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $175.77 |
| 2026-07-23 | $174.15 |
| 2026-07-22 | $172.69 |
| 2026-07-21 | $179.05 |
| 2026-07-20 | $173.00 |
| 2026-07-17 | $170.88 |
| 2026-07-16 | $171.55 |
| 2026-07-15 | $172.05 |
| 2026-07-14 | $172.04 |
| 2026-07-13 | $174.10 |
| 2026-07-10 | $177.11 |
| 2026-07-09 | $180.55 |
| 2026-07-08 | $178.24 |
| 2026-07-07 | $177.49 |
| 2026-07-06 | $174.10 |
| 2026-07-02 | $174.26 |
| 2026-07-01 | $167.77 |
| 2026-06-30 | $168.53 |
| 2026-06-29 | $170.00 |
| 2026-06-26 | $168.52 |
| 2026-06-25 | $164.18 |
| 2026-06-24 | $166.06 |
| 2026-06-23 | $161.44 |
| 2026-06-22 | $161.62 |
| 2026-06-18 | $158.29 |
| 2026-06-17 | $159.00 |
| 2026-06-16 | $156.42 |
| 2026-06-15 | $159.51 |
| 2026-06-12 | $159.76 |
| 2026-06-11 | $162.71 |
| 2026-06-10 | $160.86 |
| 2026-06-09 | $165.24 |
| 2026-06-08 | $163.12 |
| 2026-06-05 | $163.88 |
| 2026-06-04 | $167.35 |
| 2026-06-03 | $165.11 |
| 2026-06-02 | $154.84 |
| 2026-06-01 | $161.00 |
| 2026-05-29 | $158.30 |
| 2026-05-28 | $156.39 |
| 2026-05-27 | $155.83 |
| 2026-05-26 | $155.73 |
| 2026-05-22 | $156.70 |
| 2026-05-21 | $155.50 |
| 2026-05-20 | $154.67 |
| 2026-05-19 | $154.36 |
| 2026-05-18 | $157.21 |
| 2026-05-15 | $158.42 |
| 2026-05-14 | $159.05 |
| 2026-05-13 | $161.32 |
| 2026-05-12 | $155.80 |
| 2026-05-11 | $150.59 |
| 2026-05-08 | $152.25 |
| 2026-05-07 | $149.59 |
| 2026-05-06 | $147.02 |
| 2026-05-05 | $135.06 |
| 2026-05-04 | $134.07 |
| 2026-05-01 | $131.78 |
| 2026-04-30 | $131.67 |
| 2026-04-29 | $131.23 |
| 2026-04-28 | $128.12 |